SY

Synlab AGXETRA Synlab Stock Report

Last reporting period 31 Mar, 2024

Updated —

Last price

Market cap $B

2.705

Small

Exchange

XETR - Xetra

SYAB.DE Stock Analysis

SY

Uncovered

Synlab AG is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

40/100

Low score

Market cap $B

2.705

Dividend yield

Shares outstanding

219.7 B

Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The company is headquartered in Muenchen, Bayern and currently employs 29,153 full-time employees. The company went IPO on 2021-04-30. The firm is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.

View Section: Eyestock Rating